AKT1 and hepatocellular carcinoma: In contrast, our study integrated bioinformatics analyses, molecular assays, RNA sequencing, and functional validations in both in vitro and in vivo models including subcutaneous and orthotopic xenografts, to define how CGR11 facilitates HCC malignant progression through activation of the PI3K/AKT pathway and suppression of autophagy.